Although various cytokines and inflammatory mediators are upregulated in AKI, recent animal studies suggest that the use of systemic IL-6 inhibition mitigates delirium-like phenotypes in urinary tract infection [66], acute lung injury [65], and postoperative states [67]. Here, IL6 is linked to urinary tract infection.